Oral Misoprostol for Cervical Priming Before Hysteroscopy

• Status: Completed
• Trial end date: 2004-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

A randomized, double blind study to compare 200 and 400 mcg misoprostol for cervical preparation before hysteroscopy.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Saint-Joseph University
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• non pregnant patients

• considered medically fit without any life threatening conditions

• scheduled for operative hysteroscopy, regardless of age or indication of the hysteroscopy

Exclusion Criteria:

• a positive history of vascular or coronary artery disease

• using other products that could affect the consistency of the cervix such as local estrogen or laminaire